 |
|
|
| Internet Search |
|
Stock Search |
|
|
|
|
|
CONNETICS CP, (CNCT) Stock Rating Learn More
| Our Overall Rating on CONNETICS CP, CNCT is Not Available | | Connetics Corporation engages in the development and commercialization of dermatology products primarily in North America. The companys products comprise OLUX Foam, Luxiq Foam, Soriatane-brand acitretin, and Evoclin Foam. The OLUX Foam is a foam formulation of clobetasol propionate, and is used for treatment scalp and nonscalp psoriasis. The Luxiq Foam is a mid-potency steroid used for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive scalp dermatoses. The Soriatane-brand acitretin is an oral retinoid used for the treatment of severe psoriasis in adults. The Evoclin Foam is used for the treatment of acne vulgaris. The company sells its products in North America, Europe, and Australia. Connetics was incorporated in 1993 and is headquartered in Palo Alto, California. | | Our Not Available Rating on CNCT was issued on 11/21/2008 |
CONNETICS CP Technical Rating
|
|
|
|
